(Q39322974)

11 September 2017

Role of interleukin 16 in multiple myeloma (English)

1 reference

11 September 2017

0 references

16

Carsten Bokemeyer

1 reference

11 September 2017

Djordje Atanackovic

1

1 reference

11 September 2017

York Hildebrandt

2

1 reference

11 September 2017

Julia Templin

3

1 reference

11 September 2017

Yanran Cao

4

1 reference

11 September 2017

Christiane Keller

5

1 reference

11 September 2017

Jens Panse

6

1 reference

11 September 2017

Sabrina Meyer

7

1 reference

11 September 2017

Henrike Reinhard

8

1 reference

11 September 2017

Katrin Bartels

9

1 reference

11 September 2017

Nesrine Lajmi

10

1 reference

11 September 2017

Orhan Sezer

11

1 reference

11 September 2017

Axel R Zander

12

1 reference

11 September 2017

Andreas H Marx

13

1 reference

11 September 2017

Ria Uhlig

14

1 reference

11 September 2017

Jozef Zustin

15

1 reference

11 September 2017

Nicolaus Kröger

17

1 reference

11 September 2017

language of work or name

English

0 references

publication date

28 June 2012

1 reference

Journal of the National Cancer Institute

11 September 2017

1 reference

11 September 2017

104

1 reference

11 September 2017

13

1 reference

11 September 2017

1005-1020

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

11 September 2017

1 reference

Thalidomide for treatment of multiple myeloma: 10 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Chemokines in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

IL-16 is constitutively present in peripheral blood monocytes and spontaneously released during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Cultured human fibroblasts express constitutive IL-16 mRNA: cytokine induction of active IL-16 protein synthesis through a caspase-3-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Processing and activation of pro-interleukin-16 by caspase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Immunosuppressive effect on T cell activation by interleukin-16- and interleukin-10-cDNA-double-transfected human squamous cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Preferential migration of T regulatory cells induced by IL-16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

The proapoptotic Bcl-2 protein Bax plays an important role in the pathogenesis of reovirus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Functional granulocyte/macrophage colony stimulating factor receptor is constitutively expressed on neoplastic plasma cells and mediates tumour cell longevity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

IL-17 activates the canonical NF-kappaB signaling pathway in autoimmune B cells of BXD2 mice to upregulate the expression of regulators of G-protein signaling 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Characterization of clonogenic multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Interleukin-16 as a marker of Sézary syndrome onset and stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Expression of interleukin-16 by tumor-associated macrophages/activated microglia in high-grade astrocytic brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Multiple loci identified in a genome-wide association study of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Interleukin-16 in tuberculous and malignant pleural effusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Interleukin-16 inhibits immunoglobulin e production by B lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

AP-1: a double-edged sword in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Translational regulation mechanisms of AP-1 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Regulation of nuclear Prointerleukin-16 and p27(Kip1) in primary human T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Multiple myeloma cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

The CD4-associated tyrosine kinase p56lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Epigenetic silencing of the tetraspanin CD9 during disease progression in multiple myeloma cells and correlation with survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Serum level of interleukin-16 in multiple myeloma patients and its relationship to disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJS257

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJS257

1 reference

11 September 2017

1 reference